miR-218 involvement in cardiomyocyte hypertrophy is likely through targeting REST

International Journal of Molecular Sciences

Volumn 17, Issue 6, 2016, Pages

  Liu, Jing Jing ^a   Zhao, Cui Mei ^a   Li, Zhi Gang ^a   Wang, Yu Mei ^a   Miao, Wei ^a   Wu, Xiu Juan ^a   Wang, Wen Jing ^a   Liu, Chang ^a   Wang, Duo ^a   Wang, Kang ^a   Li, Li ^a   Peng, Lu Ying ^a  

^a TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Cardiomyocyte; Hypertrophy; miR 218; REST

Indexed keywords

ISOPRENALINE; MICRORNA; MIRN128 MICRORNA, MOUSE; RE1-SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN;

ANIMAL; CARDIAC MUSCLE CELL; CELL CULTURE; CHEMICALLY INDUCED; CYTOLOGY; DISEASE MODEL; DOWN REGULATION; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; MOUSE; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; STENOSIS, OCCLUSION AND OBSTRUCTION;

ANIMALS; CELLS, CULTURED; CONSTRICTION, PATHOLOGIC; DISEASE MODELS, ANIMAL; DOWN-REGULATION; GENE EXPRESSION REGULATION; ISOPROTERENOL; MICE; MICRORNAS; MYOCYTES, CARDIAC; RATS; REPRESSOR PROTEINS; SIGNAL TRANSDUCTION;

EID: 84971507674     PISSN: 16616596     EISSN: 14220067     Source Type: Journal    
DOI: 10.3390/ijms17060848     Document Type: Article

References (30)

1. Braunwald, E. The war against heart failure: The lancet lecture. Lancet 2015, 385, 812-824. [CrossRef]
2. Harvey, P.A, Leinwand, L.A. The cell biology of disease: Cellular mechanisms of cardiomyopathy. J. Cell Biol. 2011, 194, 355-365. [CrossRef] [PubMed]
3. Bartel, D.P. Micrornas: Target recognition and regulatory functions. Cell 2009, 136, 215-233. [CrossRef] [PubMed]
4. Van Rooij, E, Sutherland, L.B, Qi, X, Richardson, J.A, Hill, J, Olson, E.N. Control of stress-dependent cardiac growth and gene expression by a microRNA. Science 2007, 316, 575-579. [CrossRef] [PubMed]
5. Da Costa Martins, P.A, Bourajjaj, M, Gladka, M, Kortland, M, van Oort, R.J, Pinto, Y.M, Molkentin, J.D, de Windt, L.J. Conditional dicer gene deletion in the postnatal myocardium provokes spontaneous cardiac remodeling. Circulation 2008, 118, 1567-1576. [CrossRef] [PubMed]
6. Da Costa Martins, P.A, de Windt, L.J. Micrornas in control of cardiac hypertrophy. Cardiovasc. Res. 2012, 93, 563-572. [CrossRef] [PubMed]
7. Care, A, Catalucci, D, Felicetti, F, Bonci, D, Addario, A, Gallo, P, Bang, M.L, Segnalini, P, Gu, Y, Dalton, N.D, et al. Microrna-133 controls cardiac hypertrophy. Nat. Med. 2007, 13, 613-618. [CrossRef] [PubMed]
8. Thum, T, Condorelli, G. Long noncoding RNAs and microRNAs in cardiovascular pathophysiology. Circ. Res. 2015, 116, 751-762. [CrossRef] [PubMed]
9. Zhang, Z.H, Li, J, Liu, B.R, Luo, C.F, Dong, Q, Zhao, L.N, Zhong, Y, Chen, W.Y, Chen, M.S, Liu, S.M. Microrna-26 was decreased in rat cardiac hypertrophy model and may be a promising therapeutic target. J. Cardiovasc. Pharmacol. 2013, 62, 312-319. [CrossRef] [PubMed]
10. Huang, X, Li, Z, Bai, B, Li, X, Li, Z. High expression of microrna-208 is associated with cardiac hypertrophy via the negative regulation of the sex-determining region y-box 6 protein. Exp. Ther. Med. 2015, 10, 921-926. [CrossRef] [PubMed]
11. Huang, Z.P, Chen, J, Seok, H.Y, Zhang, Z, Kataoka, M, Hu, X, Wang, D.Z. Microrna-22 regulates cardiac hypertrophy and remodeling in response to stress. Circ. Res. 2013, 112, 1234-1243. [CrossRef] [PubMed]
12. Wang, K, Lin, Z.Q, Long, B, Li, J.H, Zhou, J, Li, P.F. Cardiac hypertrophy is positively regulated by microrna miR-23a. J. Biol. Chem. 2012, 287, 589-599. [CrossRef] [PubMed]
13. Heil, B, Tang, W.H. Biomarkers: Their potential in the diagnosis and treatment of heart failure. Clevel. Clin. J. Med. 2015, 82, 28-35.
14. Small, E.M, Sutherland, L.B, Rajagopalan, K.N, Wang, S, Olson, E.N. Microrna-218 regulates vascular patterning by modulation of slit-robo signaling. Circ. Res. 2010, 107, 1336-1344. [CrossRef] [PubMed]
15. Tu, Y, Gao, X, Li, G, Fu, H, Cui, D, Liu, H, Jin, W, Zhang, Y. Microrna-218 inhibits glioma invasion, migration, proliferation, and cancer stem-like cell self-renewal by targeting the polycomb group gene bmi1. Cancer Res. 2013, 73, 6046-6055. [CrossRef] [PubMed]
16. Venkataraman, S, Birks, D.K, Balakrishnan, I, Alimova, I, Harris, P.S, Patel, P.R, Handler, M.H, Dubuc, A, Taylor, M.D, Foreman, N.K, et al. Microrna 218 acts as a tumor suppressor by targeting multiple cancer phenotype-associated genes in medulloblastoma. J. Biol. Chem. 2013, 288, 1918-1928. [CrossRef] [PubMed]
17. Sayed, D, Hong, C, Chen, I.Y, Lypowy, J, Abdellatif, M. Micrornas play an essential role in the development of cardiac hypertrophy. Circ. Res. 2007, 100, 416-424. [CrossRef] [PubMed]
18. Thum, T, Galuppo, P, Wolf, C, Fiedler, J, Kneitz, S, van Laake, L.W, Doevendans, P.A, Mummery, C.L, Borlak, J, Haverich, A, et al. Micrornas in the human heart: A clue to fetal gene reprogramming in heart failure. Circulation 2007, 116, 258-267. [CrossRef] [PubMed]
19. Kuwahara, K. Role of nrsf/rest in the regulation of cardiac gene expression and function. Circ. J. 2013, 77, 2682-2686. [CrossRef] [PubMed]
20. Betel, D, Wilson, M, Gabow, A, Marks, D.S, Sander, C. The microRNA.Org resource: Targets and expression. Nucleic Acids Res. 2008, 36, 149-153. [CrossRef] [PubMed]
21. Yang, Y, Ago, T, Zhai, P, Abdellatif, M, Sadoshima, J. Thioredoxin 1 negatively regulates angiotensin II-induced cardiac hypertrophy through upregulation of miR-98/let-7. Circ. Res. 2011, 108, 305-313. [CrossRef] [PubMed]
22. Xia, H, Yan, Y, Hu, M, Wang, Y, Wang, Y, Dai, Y, Chen, J, Di, G, Chen, X, Jiang, X. miR-218 sensitizes glioma cells to apoptosis and inhibits tumorigenicity by regulating ecop-mediated suppression of nf-kappab activity. Neuro Oncol. 2013, 15, 413-422. [CrossRef] [PubMed]
23. Rohini, A, Agrawal, N, Koyani, C.N, Singh, R. Molecular targets and regulators of cardiac hypertrophy. Pharmacol. Res. 2010, 61, 269-280. [CrossRef] [PubMed]
24. Cox, E.J, Marsh, S.A. A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes. PLoS ONE 2014, 9, e92903. [CrossRef] [PubMed]
25. Aksoy, I, Marcy, G, Chen, J, Divakar, U, Kumar, V, John-Sanchez, D, Rahmani, M, Buckley, N.J, Stanton, L.W. A role for rest in embryonic stem cells cardiac lineage specification. Stem Cells 2016, 34, 860-872. [CrossRef] [PubMed]
26. Hassan, M.Q, Maeda, Y, Taipaleenmaki, H, Zhang, W, Jafferji, M, Gordon, J.A, Li, Z, Croce, C.M, van Wijnen, A.J, Stein, J.L, et al. miR-218 directs a wnt signaling circuit to promote differentiation of osteoblasts and osteomimicry of metastatic cancer cells. J. Biol. Chem. 2012, 287, 42084-42092. [CrossRef] [PubMed]
27. Cho, E, Moon, S.M, Park, B.R, Kim do, K, Lee, B.K, Kim, C.S. Nrsf/rest regulates the mtor signaling pathway in oral cancer cells. Oncol. Rep. 2015, 33, 1459-1464. [CrossRef] [PubMed]
28. Zhang, X, Shi, H, Tang, H, Fang, Z, Wang, J, Cui, S. miR-218 inhibits the invasion and migration of colon cancer cells by targeting the PI3K/AKT/mTOR signaling pathway. Int. J. Mol. Med. 2015, 35, 1301-1308. [CrossRef] [PubMed]
29. Tomasoni, R, Negrini, S, Fiordaliso, S, Klajn, A, Tkatch, T, Mondino, A, Meldolesi, J, D’Alessandro, R. A signaling loop of rest, TSC2 and-catenin governs proliferation and function of pc12 neural cells. J. Cell Sci. 2011, 124, 3174-3186. [CrossRef] [PubMed]
30. Gao, C, Zhang, Z, Liu, W, Xiao, S, Gu, W, Lu, H. Reduced microRNA-218 expression is associated with high nuclear factor b activation in gastric cancer. Cancer 2010, 116, 41-49. [PubMed]